Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Smith & Nephew Endoscopy unit marks medical device milestone

April 6, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The Andover-based Endoscopy division of Smith & Nephew plc, a medical devices firm with headquarters in London, has had its flagship product, the TRUCLEAR System, hit 30,000 procedures.

Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010

April 6, 2011 8:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 6, 2011 /- TriMarkPublications.com cites in its newly published " Medical Imaging Markets" report that global spending on medical imaging equipment exceeded $21 billion in 2010. For more information, visit:...

United Nations Urged to Ban Mercury in Vaccines

April 6, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., April 6, 2011 /PRNewswire-USNewswire/ -- CoMeD – While the United Nations (UN) actively questions the use of vaccines containing a neurotoxic mercury compound, the Coalition for Mercury-Free Drugs (CoMeD), a Maryland-based, non-profit organization, is urging the...

Advertisement

KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies

April 6, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 6, 2011 /- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has signed an exclusive agreement with AdnaGen, a wholly-owned subsidiary of Alere, Inc., to...

MIT's Koch Institute to use Roche LightCycler 480 System to Help Advance Cancer Research

April 6, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, April 6,  2011 /- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler ® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of...

Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes

April 6, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

MALIBU, Calif., April 6, 2011 /- Cliffside Malibu, one of America's leading drug and alcohol treatment centers, is strongly urging its patients who are currently taking antidepressants not to stop, despite a new study and subsequent media reports that such drugs could raise the risk of...

Yervoy (ipilimumab): Risk Evaluation and Mitigation Strategy (REMS) - Severe Immune-Mediated Adverse Reactions

April 6, 2011 7:30 am | by U.S. Food & Drug Administration | News | Comments

The most common severe reactions include enterocolitis, hepatitis, dermatitis (including toxic epidermal necrolysis), neuropathy, and endocrinopathy.

FDA Clears Mandometer® for the Treatment of Eating Disorders

April 6, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 6, 2011 /- The U.S. Food and Drug Administration announced on March 31 that it had cleared Mandometer® for the treatment of patients with eating disorders.   Mandometer® is an innovative device that provides biofeedback allowing individuals to monitor their...

Advertisement

Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results

April 6, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

LIVINGSTON, N.J. and MORRISTOWN, N.J., April 6, 2011 /- Columbia Laboratories, Inc. (Nasdaq: CBRX ), and Watson Pharmaceuticals, Inc. (NYSE: WPI ), today announced the publication of Phase III PROCHIEVE® (progesterone gel) data in today's online version of Ultrasound in Obstetrics...

CVS/pharmacy Debuts the "To Your Health" Program in Atlanta Bringing 60 Free Health Screening Events to the Community

April 6, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

ATLANTA, April 6, 2011 /- CVS/pharmacy, the nation's leading retail pharmacy, brings its "To Your Health" free health screening program to Atlanta on Saturday, April 9. The program will provide free preventive health screenings for Atlanta area residents at 60 events now through November...

Michael Douglas, Honored Film Star and Throat Cancer Survivor, Encourages Public to Attend Free Local Screenings During Oral, Head & Neck Cancer Awareness Week

April 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 6, 2011 /- Academy Award-winning actor and producer Michael Douglas, who is recovering from a battle with throat cancer, is urging Americans to get screened for cancer during the 14th annual Oral, Head & Neck Cancer Awareness Week (OHANCAW), being held nationwide May...

Caliper Life Sciences Announces Date and Location of its 2011 Annual Meeting of Stockholders

April 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., April 6, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that its 2011 Annual Meeting of Stockholders will be held on June 2, 2011, at 10:00 a.m. local time at its offices located at 68 Elm Street, Hopkinton, Massachusetts.  The record date for...

Philips to Take Orders for the Ingenia MRI System in the United States

April 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

ANDOVER, Mass., April 6, 2011 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the United States availability of the Ingenia MRI system, the first-ever digital broadband magnetic resonance imaging (MRI) solution. Previously available in Europe, Canada and...

Advertisement

Cardica Receives Key Patent for Microcutterâ„¢ Surgical Cutting and Stapling Device

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., April 6, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the company Patent No. 7,918,376 for its proprietary Microcutter™ technology. This patent relates to the articulation of a surgical...

Aethlon Medical Releases Shareholder Letter

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 6, 2011 /- Aethlon Medical, Inc., (OTCBB: AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. (Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) To our Shareholders: On April 1st, we...

CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 6, 2011 /- CareFusion (NYSE: CFN ), a leading global medical technology company, today announced it has acquired technology to automate the segregation of pharmaceutical waste, helping hospitals reduce cost, improve regulatory controls and facilitate environmental...

e-MDs Selected by Medical Society of the State of New York

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, April 6, 2011 /- e-MDs, a leading provider of electronic health records (EHRs), announced they have been selected as an EHR vendor partner by the Medical Society of the State of New York (MSSNY).  MSSNY is a non-profit organization committed to representing the medical...

Kimberly-Clark Health Care Announces Strategic Green Partnerships, Commitment to Reducing Medical Waste

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

ROSWELL, Ga., April 6, 2011 /- Kimberly-Clark Health Care today announced achievements that highlight the company's substantial progress in its sustainability initiatives.  From rewarding customers for their sustainability efforts to developing recyclable uses for medical packaging...

MEDX Installs Two Next Generation T-Questâ„¢ Compact Gamma Cameras

April 6, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

ARLINGTON HEIGHTS, Ill., April 6, 2011 /PRNewswire/ -- MEDX, Inc., a leading provider of nuclear medicine equipment, today introduced the next generation T-Quest™ compact gamma camera.  The FDA-cleared T-Quest, includes enhanced thyroid imaging and now features expanded imaging...

Study Shows Positron Emission Mammography (PEM) is Easy for Breast Imagers to Learn Regardless of Experience

April 6, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 6, 2011 /- The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of  the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.  The first study...

REMINDER: PositiveID Corporation to Host WebEx of Its iglucose Diabetes Management Mobile Health Solution for Interested Licensees, Physicians, Patients, Payors and Investors

April 6, 2011 5:33 am | by PositiveID | News | Comments

REMINDER: PositiveID Corporation to Host WebEx of Its iglucose Diabetes Management Mobile Health Solution for Interested Licensees, Physicians, Patients, Payors and Investors

Strawberries May Slow Precancerous Growth in Esophagus

April 6, 2011 5:32 am | by AACR | News | Comments

Tweet • Esophageal cancer is the third most common gastrointestinal cancer. • Six months of eating strawberry may decrease histological grade of precancerous lesions. • Strawberries may reduce cancer-related molecular events. ORLANDO, Fla. - Freeze-dried strawberries may be an alternative...

GOLFIG Increased Progression-free Survival in Colorectal Cancer Patients

April 6, 2011 5:32 am | by AACR | News | Comments

Tweet • Duration of progression-free survival was 16.5 months with GOLFIG. • GOLFIG is safe and effective in patients with metastatic colorectal cancer. • Study prematurely terminated due to superior results of GOLFIG. ORLANDO, Fla. - Oncologists can use colorectal cancer patients' own...

Physical Health Scores Predict Breast Cancer Outcomes

April 6, 2011 5:32 am | by AACR | News | Comments

Tweet • Risk of recurrence increased in women with poor health scores. • Five percent improvement in physical health score can reduce risk. ORLANDO, Fla. - Breast cancer survivors with poor physical health scores had an elevated risk of poorer cancer outcomes, including recurrence and...

Oxford BioTherapeutics Licenses BioWa's POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer

April 6, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., and OXFORD, England, April 6, 2011 /- BioWa, Inc. (BioWa) and Oxford BioTherapeutics Ltd (OBT) today announced that they have entered into a license agreement to provide OBT with access to BioWa's patented POTELLIGENT® Technology platform for the development of...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading